Disclosed is a method of expressing enzymatically-active, recombinant human .beta.-tryptase in a yeast host cell, expression constructs which drive the production of enzymatically-active tryptase in transformed yeast, and genetically-engineered yeast containing the expression constructs and which express enzymatically-active human .beta.-tryptase. Uses for the tryptase so produced are also disclosed.

 
Web www.patentalert.com

< (none)

< Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios

> Compounds having activity as inhibitors of cytochrome P450RAI

> (none)

~ 00032